Molecular Modeling and Affinity Determination of scFv Antibody: Proper Linker Peptide Enhances Its Activity
Open Access
- 9 October 2009
- journal article
- research article
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 38 (2) , 537-549
Abstract
One of existing strategies to engineer active antibody is to link V H and V L domains via a linker peptide. How the composition, length, and conformation of the linker affect antibody activity, however, remains poorly understood. In this study, a dual approach that coordinates molecule modeling, biological measurements, and affinity evaluation was developed to quantify the binding activity of a novel stable miniaturized anti-CD20 antibody or single-chain fragment variable (scFv) with a linker peptide. Upon computer-guided homology modeling, distance geometry analysis, and molecular superimposition and optimization, three new linker peptides PT1, PT2, and PT3 with respective 7, 10, and 15 residues were proposed and three engineered antibodies were then constructed by linking the cloned V H and V L domains and fusing to a derivative of human IgG1. The binding stability and activity of scFv-Fc chimera to CD20 antigen was quantified using a micropipette adhesion frequency assay and a Scatchard analysis. Our data indicated that the binding affinity was similar for the chimera with PT2 or PT3 and ~24-fold higher than that for the chimera with PT1, supporting theoretical predictions in molecular modeling. These results further the understanding in the impact of linker peptide on antibody structure and activity.Keywords
This publication has 42 references indexed in Scilit:
- Evaluation of Staphylococcal Cell Surface Display and Flow Cytometry for Postselectional Characterization of Affinity Proteins in Combinatorial Protein Engineering ApplicationsApplied and Environmental Microbiology, 2007
- Optimizing the Generation of Recombinant Single-Chain Antibodies Against Placental Alkaline PhosphataseHybridoma, 2006
- Properties of a single-chain antibody containing different linker peptidesProtein Engineering, Design and Selection, 1995
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- CD20: a regulator of cell-cycle progression of B lymphocytesImmunology Today, 1994
- Characterisation of a recombinant Fv fragment of anti-MUC1 antibody HMFG1Cancer Letters, 1994
- Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extensionGene, 1989
- Single-Chain Antigen-Binding ProteinsScience, 1988
- The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3Nature, 1987
- Computer simulation as a tool for tracing the conformational differences between proteins in solution and in the crystalline stateJournal of Molecular Biology, 1984